Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Evgen Pharma ( (GB:TCF) ) has provided an announcement.
Theracryf PLC, a UK-based company, has announced a change in its major holdings. First Equity Limited, acting as an investment manager for Armstrong Investments Limited, has increased its voting rights in Theracryf PLC to 8.405246%, up from a previous position of 6.113760%. This acquisition of voting rights indicates a significant shift in shareholder influence, potentially impacting the company’s strategic decisions and market positioning.
More about Evgen Pharma
YTD Price Performance: -56.73%
Average Trading Volume: 3,792,212
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £4.79M
Learn more about TCF stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue